Decision support reduces antibiotic usage for bronchitis

January 15, 2013
Decision support reduces antibiotic usage for bronchitis
Decision support strategies can help reduce the over-prescription of antibiotics for acute bronchitis in primary care settings, according to a study published online Jan. 14 in JAMA Internal Medicine.

(HealthDay)—Decision support strategies can help reduce the over-prescription of antibiotics for acute bronchitis in primary care settings, according to a study published online Jan. 14 in JAMA Internal Medicine.

Ralph Gonzales, M.D., M.S.P.H., from the University of California in San Francisco, and colleagues compared the effect of two decision support strategies on of uncomplicated acute bronchitis in a randomized study involving 33 primary care practices in an integrated . The practices were randomized in a 1:1:1 ratio to receive printed decision support for acute cough illness, computer-assisted decision support through , or control sites. Intervention sites also received clinician education and feedback on prescribing practices as well as patient education brochures. Antibiotic prescription rates were compared for the winter period following introduction of the intervention and the previous three winter periods.

The researchers found that during the intervention period the percentage of adolescents and adults prescribed antibiotics declined at the printed decision and computer-assisted support sites (from 80.0 to 68.3 percent and from 74.0 to 60.7 percent, respectively), while at control sites there was a slight increase (from 72.5 to 74.3 percent). The differences in prescribing at the intervention sites were significant compared to the control sites, after adjustment for patient and clinician characteristics. There were no significant other differences between the intervention sites.

"In conclusion, an evidence-based algorithm to guide management of acute bronchitis can reduce the in primary care settings, but the mode of implementation does not seem to influence the magnitude of effect," the authors write.

Two authors disclosed financial ties to the pharmaceutical and medical informatics industries.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Use of clinical decision-support system can improve HIV care

December 4, 2012

(HealthDay)—Use of a clinical decision-support system (CDSS) appears to be beneficial in HIV care, with improvements noted in CD4 cell counts and clinic follow-up, according to a study published in the Dec. 4 issue of the ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.